Loading chat...
PA HB602
Bill
Status
2/12/2025
Primary Sponsor
Mary Isaacson
Click for details
AI Summary
-
Requires drug manufacturers and distributors to obtain annual licenses from the Department of Health, with fees of $27,500 for opiate-containing controlled substances and $2,500 for other drugs or devices
-
Imposes an annual $250,000 assessment on manufacturers that sell, deliver, or distribute 2 million or more units of opiates within Pennsylvania
-
Establishes the Opioid Reparation and Accountability Fund as a restricted State Treasury account to receive all licensing fees and assessments for opioid epidemic response efforts
-
Creates the Opiate Epidemic Response Advisory Council, chaired by the Secretary of Health, to develop statewide strategies addressing opioid addiction through prevention, education, treatment expansion, and grant recommendations
-
Mandates annual reporting by manufacturers, distributors, and pharmacy owners on all opiate sales and distributions within Pennsylvania, beginning March 1, 2026
Legislative Description
Providing for opioid stewardship; establishing the Opioid Reparation and Accountability Fund and the Opiate Epidemic Response Advisory Council; and imposing duties on the Department of Health, the Department of Human Services and the Department of Drug and Alcohol Programs.
Last Action
Referred to Health
2/12/2025